chr2-84796430-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001370.2(DNAH6):c.11359+5A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.168 in 1,498,844 control chromosomes in the GnomAD database, including 23,880 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001370.2 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH6 | NM_001370.2 | c.11359+5A>G | splice_region_variant, intron_variant | ENST00000389394.8 | NP_001361.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH6 | ENST00000389394.8 | c.11359+5A>G | splice_region_variant, intron_variant | 5 | NM_001370.2 | ENSP00000374045.3 |
Frequencies
GnomAD3 genomes AF: 0.225 AC: 34190AN: 151944Hom.: 4587 Cov.: 32
GnomAD3 exomes AF: 0.174 AC: 22643AN: 130108Hom.: 2279 AF XY: 0.169 AC XY: 11648AN XY: 68916
GnomAD4 exome AF: 0.162 AC: 218027AN: 1346782Hom.: 19269 Cov.: 26 AF XY: 0.162 AC XY: 107328AN XY: 662922
GnomAD4 genome AF: 0.225 AC: 34259AN: 152062Hom.: 4611 Cov.: 32 AF XY: 0.222 AC XY: 16545AN XY: 74362
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
DNAH6-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at